No photo of Al B Benson III

View Scopus Profile

Al B Benson III

  • 35229 Citations
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Colon cancer, Gastric cancer, Pancreas cancer, Rectal cancer

Certifications and Licenses

Internal Medicine
Medical Oncology

Training Experience

1979Residency, Univ. of Wisconsin Hospital
1984Fellowship, Univ. of Wisconsin Hospital

Education/Academic qualification

MD, SUNY Buffalo

… → 1976

Research interests

  • Anal Cancer
  • Colon/Rectal Cancer
  • Esophageal Cancer
  • GI Stromal Tumors
  • Gastrointestinal Malignancies
  • Liver Cancer
  • Neuroendocrine Tumors
  • Pancreatic Cancer
  • Stomach Cancer

Fingerprint Dive into the research topics where Al B Benson III is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Combinational DC vaccines and interventional Irreversible Electroporation for pancreatic ductal adenocarcinoma therapy.

Benson III, A. B., Ji, P., Salem, R., Zhang, Z. & Zhang, Z.

SIR Foundation

6/1/20 → 5/31/21

Project: Research project

    • Image-guided Interventional Combination Liver Cancer Immunotherapy

    Benson III, A. B., Ji, P., Salem, R., Velichko, Y., Yaghmai, V. & Zhang, Z.

    National Cancer Institute

    3/15/20 → 2/28/25

    Project: Research project

    • Prot #BTCRC-GI18-149: Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

    Benson III, A. B.

    Hoosier Cancer Research Network, Inc., Lilly USA, LLC

    1/21/20 → 1/21/23

    Project: Research project

    ECOG-ACRIN Master Services Agreement 2020

    Benson III, A. B.

    ECOG-ACRIN Medical Research Foundation, Inc., National Cancer Institute

    1/1/20 → 12/31/24

    Project: Research project

    Prot #PANC003: A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

    Benson III, A. B.

    Covance Inc., Rafael Pharmaceuticals, Inc.

    10/25/19 → 10/25/22

    Project: Research project

    Research Output

    Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study

    Benson, A. B., Strosberg, J., Joish, V. N., Dharba, S., Sapre, D. & Lapuerta, P., Mar 1 2020, In : Pancreas. 49, 3, p. 408-412 5 p.

    Research output: Contribution to journal › Article

    • Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation (CardioVascular and Interventional Radiology, (2019), 42, 5, (700-711), 10.1007/s00270-019-02191-z)

    Ali, R., Yang, Y., Antkowiak, M., Gabr, A., Mora, R., Abouchaleh, N., Asadi, A. A., Kulik, L., Ganger, D., Abecassis, M. M., Katariya, N., Mulcahy, M., Benson, A., Mahalingam, D., Thornburg, B., Mouli, S., Lewandowski, R. J., Salem, R. & Riaz, A., May 1 2020, In : Cardiovascular and Interventional Radiology. 43, 5, 1 p.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Dinaciclib prolongs survival in the LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma

    Yang, J., Hu, S., Shangguan, J., Eresen, A., Li, Y., Ma, Q., Yaghmai, V., Benson, A. B. & Zhang, Z., Jan 1 2020, In : American Journal of Translational Research. 12, 3, p. 1031-1043 13 p.

    Research output: Contribution to journal › Article

    • Failure to administer recommended chemotherapy: Acceptable variation or cancer care quality blind spot?

    Ellis, R. J., Schlick, C. J. R., Feinglass, J., Mulcahy, M. F., Benson, A. B., Kircher, S. M., Yang, T. D., Odell, D. D., Bilimoria, K. & Merkow, R. P., Feb 1 2020, In : BMJ Quality and Safety. 29, 2, p. 103-112 10 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

    on behalf of the NETTER-1 study group, Jan 1 2020, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journal › Article

    Open Access